The G protein‐coupled receptors deorphanization landscape
暂无分享,去创建一个
J. Hanson | Céline Laschet | Nadine Dupuis | Julien Hanson | Nadine Dupuis | Céline Laschet | N. Dupuis | C. Laschet
[1] K. Su,et al. A novel endothelin receptor type-B-like gene enriched in the brain. , 1997, Biochemical and biophysical research communications.
[2] C. Langmead,et al. Murine GPRC6A Mediates Cellular Responses to L-Amino Acids, but Not Osteocalcin Variants , 2016, PloS one.
[3] K. Hansen,et al. Pharmacological characterization of mouse GPRC6A, an L‐α‐amino‐acid receptor modulated by divalent cations , 2007, British journal of pharmacology.
[4] J. Corbett,et al. Neuronostatin inhibits glucose-stimulated insulin secretion via direct action on the pancreatic α-cell. , 2014, American journal of physiology. Endocrinology and metabolism.
[5] C. Bowers. History to the discovery of ghrelin. , 2012, Methods in enzymology.
[6] C. Serhan,et al. Resolvin D1 binds human phagocytes with evidence for proresolving receptors , 2010, Proceedings of the National Academy of Sciences.
[7] Nitin J. Karandikar,et al. The oligodendrocyte-specific G-protein coupled receptor GPR17 is a cell-intrinsic timer of myelination , 2009, Nature Neuroscience.
[8] J. Violin,et al. β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection , 2007 .
[9] N. Bunnett,et al. Protease-activated receptors: contribution to physiology and disease. , 2004, Physiological reviews.
[10] Marc Parmentier,et al. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family , 2009, Pharmacological Reviews.
[11] Arthur Christopoulos,et al. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview , 2017, British journal of pharmacology.
[12] R. Sunahara,et al. Genetic evidence that β-arrestins are dispensable for the initiation of β2-adrenergic receptor signaling to ERK , 2017, Science Signaling.
[13] Rob Leurs,et al. Pharmacogenomic and structural analysis of constitutive g protein-coupled receptor activity. , 2007, Annual review of pharmacology and toxicology.
[14] Gorjan Alagic,et al. #p , 2019, Quantum information & computation.
[15] 이화영. X , 1960, Chinese Plants Names Index 2000-2009.
[16] P. Bonaventure,et al. Identification and SAR of Glycine Benzamides as Potent Agonists for the GPR139 Receptor. , 2015, ACS medicinal chemistry letters.
[17] M. Freissmuth,et al. Recruitment of a Cytoplasmic Chaperone Relay by the A2A Adenosine Receptor , 2013, The Journal of Biological Chemistry.
[18] Wei Liu,et al. Successful Strategies to Determine High-Resolution Structures of GPCRs. , 2016, Trends in pharmacological sciences.
[19] Seon-Young Kim,et al. GPR171 expression enhances proliferation and metastasis of lung cancer cells , 2016, Oncotarget.
[20] Charles N. Serhan,et al. Infection Regulates Pro-Resolving Mediators that Lower Antibiotic Requirements , 2012, Nature.
[21] Adam J Pawson,et al. International Union of Basic and Clinical Pharmacology. LXXXVIII. G Protein-Coupled Receptor List: Recommendations for New Pairings with Cognate Ligands , 2013, Pharmacological Reviews.
[22] Jeffrey A. Porter,et al. A natural ligand for the orphan receptor GPR15 modulates lymphocyte recruitment to epithelia , 2017, Science Signaling.
[23] R. Graham,et al. Metalloprotease cleavage of the N terminus of the orphan G protein–coupled receptor GPR37L1 reduces its constitutive activity , 2016, Science Signaling.
[24] A. Kuliopulos,et al. Turning Receptors On and Off with Intracellular Pepducins: New Insights into G-protein-coupled Receptor Drug Development* , 2012, The Journal of Biological Chemistry.
[25] S. Ferguson,et al. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. , 2001, Pharmacological reviews.
[26] J. Krause,et al. C5L2, a nonsignaling C5A binding protein. , 2003, Biochemistry.
[27] O. Civelli,et al. Orphan GPCR research , 2008, British journal of pharmacology.
[28] K. Desai,et al. Targeted Disruption of the β2 Adrenergic Receptor Gene* , 1999, The Journal of Biological Chemistry.
[29] R. A. Hall,et al. Fine-tuning of GPCR activity by receptor-interacting proteins , 2009, Nature Reviews Molecular Cell Biology.
[30] T. Kenakin. Biased signalling and allosteric machines: new vistas and challenges for drug discovery , 2012, British journal of pharmacology.
[31] A. IJzerman,et al. Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery. , 2006, Trends in pharmacological sciences.
[32] H. Bradshaw,et al. A GPR18‐based signalling system regulates IOP in murine eye , 2013, British journal of pharmacology.
[33] A. IJzerman,et al. Human G protein-coupled receptor studies in Saccharomyces cerevisiae. , 2016, Biochemical pharmacology.
[34] Peter M. Jones,et al. The novel chemokine receptor, G-protein-coupled receptor 75, is expressed by islets and is coupled to stimulation of insulin secretion and improved glucose homeostasis , 2013, Diabetologia.
[35] J. Reagan,et al. Kynurenic Acid as a Ligand for Orphan G Protein-coupled Receptor GPR35* , 2006, Journal of Biological Chemistry.
[36] H. Schaller,et al. Conserved amino acid sequence of a neuropeptide, the head activator, from coelenterates to humans , 1981, Nature.
[37] C. Serhan,et al. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor , 1994, The Journal of experimental medicine.
[38] C. Dahlgren,et al. What Formyl Peptide Receptors, if Any, Are Triggered by Compound 43 and Lipoxin A4? , 2011, Scandinavian journal of immunology.
[39] C. Dahlgren,et al. Lipoxin A4 Metabolites/Analogues from Two Commercial Sources have No Effects on TNF‐α‐mediated Priming or Activation through the Neutrophil Formyl Peptide Receptors , 2009, Scandinavian journal of immunology.
[40] A. Sher,et al. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 , 2005, The Journal of experimental medicine.
[41] Kirsten B. Andersen,et al. The GPR139 reference agonists 1a and 7c, and tryptophan and phenylalanine share a common binding site , 2017, Scientific Reports.
[42] E. Butcher,et al. Orphan chemoattractant receptor GPR15 mediates dendritic epidermal T‐cell recruitment to the skin , 2014, European journal of immunology.
[43] David E. Gloriam,et al. Computer-Aided Discovery of Aromatic l-α-Amino Acids as Agonists of the Orphan G Protein-Coupled Receptor GPR139 , 2014, J. Chem. Inf. Model..
[44] M. Trincavelli,et al. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl‐leukotrienes receptor , 2006, The EMBO journal.
[45] J. Twizere,et al. Activation of the Orphan G Protein–Coupled Receptor GPR27 by Surrogate Ligands Promotes β-Arrestin 2 Recruitment , 2017, Molecular Pharmacology.
[46] T. Schöneberg,et al. A tethered agonist within the ectodomain activates the adhesion G protein-coupled receptors GPR126 and GPR133. , 2014, Cell reports.
[47] T. Horvath,et al. FoxO 1 Target Gpr 17 Activates AgRP Neurons to Regulate Food Intake , 2016 .
[48] Gebräuchliche Fertigarzneimittel,et al. V , 1893, Therapielexikon Neurologie.
[49] S. Carr,et al. Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior , 1998, Cell.
[50] T. Schöneberg,et al. The constitutive activity of the adhesion GPCR GPR114/ADGRG5 is mediated by its tethered agonist , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[51] R. Leurs,et al. Quantitative expression profiling of G‐protein‐coupled receptors (GPCRs) in metastatic melanoma: the constitutively active orphan GPCR GPR18 as novel drug target , 2011, Pigment cell & melanoma research.
[52] S. Mani,et al. The metabolite GnRH-(1-5) inhibits the migration of immortalized GnRH neurons. , 2013, Endocrinology.
[53] Mingyao Liu,et al. Elimination of GPR146‐mediated antiviral function through IRF3/HES1‐signalling pathway , 2017, Immunology.
[54] S. Hornemann,et al. The prion protein is an agonistic ligand of the G protein-coupled receptor Adgrg6 , 2016, Nature.
[55] L. Quarles,et al. Identification of a Novel Extracellular Cation-sensing G-protein-coupled Receptor* , 2005, Journal of Biological Chemistry.
[56] S. Sentellas,et al. Lack of activity of 15‐epi‐lipoxin A4 on FPR2/ALX and CysLT1 receptors in interleukin‐8‐driven human neutrophil function , 2013, Clinical and experimental immunology.
[57] V. B. Lu,et al. N-Arachidonyl Glycine Does Not Activate G Protein–Coupled Receptor 18 Signaling via Canonical Pathways , 2013, Molecular Pharmacology.
[58] J. V. Moran,et al. Initial sequencing and analysis of the human genome. , 2001, Nature.
[59] M. Parmentier,et al. Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism. , 2011, Cytokine & growth factor reviews.
[60] H. Schiöth,et al. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. , 2003, Molecular pharmacology.
[61] D. Bechtold,et al. GPR50 Interacts with TIP60 to Modulate Glucocorticoid Receptor Signalling , 2011, PloS one.
[62] S. Mani,et al. β-Arrestin 2 is a mediator of GnRH-(1-5) signaling in immortalized GnRH neurons. , 2013, Endocrinology.
[63] Michelle M. Giddens,et al. GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin , 2013, Proceedings of the National Academy of Sciences.
[64] N. Ferreirós,et al. Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A₄. , 2013, Biochemical pharmacology.
[65] Ruben Abagyan,et al. Identifying ligands at orphan GPCRs: current status using structure‐based approaches , 2016, British journal of pharmacology.
[66] M. Duggan,et al. Orphan seven transmembrane domain receptors: reversing pharmacology. , 1994, Trends in pharmacological sciences.
[67] G. Milligan. G protein‐coupled receptors not currently in the spotlight: free fatty acid receptor 2 and GPR35 , 2017, British journal of pharmacology.
[68] T. Kohout,et al. Regulation of Receptor Fate by Ubiquitination of Activated β2-Adrenergic Receptor and β-Arrestin , 2001, Science.
[69] D. Im,et al. GPR35 mediates lodoxamide‐induced migration inhibitory response but not CXCL17‐induced migration stimulatory response in THP‐1 cells; is GPR35 a receptor for CXCL17? , 2018, British journal of pharmacology.
[70] Jonathan R. Tomshine,et al. Conformational biosensors reveal GPCR signalling from endosomes , 2013, Nature.
[71] Maria F. Sassano,et al. A Pharmacological Organization of G Protein-coupled Receptors , 2012, Nature Methods.
[72] H. Schiöth,et al. G protein-coupled receptor deorphanizations. , 2013, Annual review of pharmacology and toxicology.
[73] Dipendra K. Aryal,et al. GPR171 is a hypothalamic G protein-coupled receptor for BigLEN, a neuropeptide involved in feeding , 2013, Proceedings of the National Academy of Sciences.
[74] Z. Ou,et al. The role and clinical significance of the CXCL17-CXCR8 (GPR35) axis in breast cancer. , 2017, Biochemical and biophysical research communications.
[75] S. Di,et al. ProSAAS-Derived Peptides are Colocalized with Neuropeptide Y and Function as Neuropeptides in the Regulation of Food Intake , 2011, PloS one.
[76] Kirsten B. Andersen,et al. Novel Agonist Bioisosteres and Common Structure-Activity Relationships for The Orphan G Protein-Coupled Receptor GPR139 , 2016, Scientific Reports.
[77] Marc Parmentier,et al. Specific Recruitment of Antigen-presenting Cells by Chemerin, a Novel Processed Ligand from Human Inflammatory Fluids , 2003, The Journal of experimental medicine.
[78] M. Smit,et al. Cutting Edge: GPR35/CXCR8 Is the Receptor of the Mucosal Chemokine CXCL17 , 2015, The Journal of Immunology.
[79] W. Zgrajka,et al. Micromolar concentration of kynurenic acid in rat small intestine , 2008, Amino Acids.
[80] H. Schaller,et al. RANTES stimulates Ca2+ mobilization and inositol trisphosphate (IP3) formation in cells transfected with G protein‐coupled receptor 75 , 2006, British journal of pharmacology.
[81] 장윤희,et al. Y. , 2003, Industrial and Labor Relations Terms.
[82] L. Pardo,et al. The Parkinson's disease‐associated GPR37 receptor‐mediated cytotoxicity is controlled by its intracellular cysteine‐rich domain , 2013, Journal of neurochemistry.
[83] U. Bogdahn,et al. Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug , 2015, Nature Communications.
[84] M. Rask-Andersen,et al. Trends in the exploitation of novel drug targets , 2011, Nature Reviews Drug Discovery.
[85] Philippe Delagrange,et al. The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerization , 2006, The EMBO journal.
[86] Xin Chen,et al. Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65 , 2015, Nature.
[87] R. Xu,et al. GPR15-Mediated Homing Controls Immune Homeostasis in the Large Intestine Mucosa , 2013, Science.
[88] Takao Shimizu,et al. The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo , 2006, Pharmacological Reviews.
[89] T. Saito,et al. An evolutionarily conserved G-protein coupled receptor family, SREB, expressed in the central nervous system. , 2000, Biochemical and biophysical research communications.
[90] W. Samson,et al. Evidence for an interaction of neuronostatin with the orphan G protein-coupled receptor, GPR107. , 2012, American journal of physiology. Regulatory, integrative and comparative physiology.
[91] R. Jockers,et al. Alternative drug discovery approaches for orphan GPCRs. , 2008, Drug discovery today.
[92] H. Biebermann,et al. Insights into Basal Signaling Regulation, Oligomerization, and Structural Organization of the Human G-Protein Coupled Receptor 83 , 2016, PloS one.
[93] Atsushi Inoue,et al. Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18. , 2006, Biochemical and biophysical research communications.
[94] Yunpeng Wu,et al. GPRC6A mediates the effects of L-arginine on insulin secretion in mouse pancreatic islets. , 2012, Endocrinology.
[95] S. Mani,et al. GnRH-(1-5) transactivates EGFR in Ishikawa human endometrial cells via an orphan G protein-coupled receptor. , 2014, Molecular endocrinology.
[96] G. Milligan,et al. Interactions between the Mas-Related Receptors MrgD and MrgE Alter Signalling and Trafficking of MrgD , 2006, Molecular Pharmacology.
[97] Tsuyoshi Murata,et al. {m , 1934, ACML.
[98] T. Hökfelt,et al. Distribution of an orphan G-protein coupled receptor (JP05) mRNA in the human brain , 2001, Brain Research.
[99] T. Schöneberg,et al. Gpr126 Functions in Schwann Cells to Control Differentiation and Myelination via G-Protein Activation , 2013, The Journal of Neuroscience.
[100] H. Baba,et al. Cloning of a G‐protein‐coupled receptor that shows an activity to transform NIH3T3 cells and is expressed in gastric cancer cells , 2004, Cancer science.
[101] G Vassart,et al. Selective amplification and cloning of four new members of the G protein-coupled receptor family. , 1989, Science.
[102] R. Jockers,et al. Techniques for the discovery of GPCR-associated protein complexes. , 2013, Methods in enzymology.
[103] D. Attwell,et al. G protein‐coupled receptor 37‐like 1 modulates astrocyte glutamate transporters and neuronal NMDA receptors and is neuroprotective in ischemia , 2017, Glia.
[104] T. Schöneberg,et al. The Adhesion GPCR GPR126 Has Distinct, Domain-Dependent Functions in Schwann Cell Development Mediated by Interaction with Laminin-211 , 2015, Neuron.
[105] E. Kostenis,et al. The Orphan Receptor GPR17 Is Unresponsive to Uracil Nucleotides and Cysteinyl Leukotrienes , 2017, Molecular Pharmacology.
[106] Bryan L Roth,et al. Discovery of new GPCR ligands to illuminate new biology. , 2017, Nature chemical biology.
[107] S. Rees,et al. Screening β-Arrestin Recruitment for the Identification of Natural Ligands for Orphan G-Protein–Coupled Receptors , 2013, Journal of biomolecular screening.
[108] Richard R. Neubig,et al. International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List , 2005, Pharmacological Reviews.
[109] S. Woods,et al. The orphan receptor Gpr83 regulates systemic energy metabolism via ghrelin-dependent and ghrelin-independent mechanisms , 2013, Nature Communications.
[110] T. Benned-Jensen,et al. Distinct expression and ligand-binding profiles of two constitutively active GPR17 splice variants , 2010, British journal of pharmacology.
[111] J. Brenchley,et al. Simian Immunodeficiency Virus SIVagm Efficiently Utilizes Non-CCR5 Entry Pathways in African Green Monkey Lymphocytes: Potential Role for GPR15 and CXCR6 as Viral Coreceptors , 2015, Journal of Virology.
[112] C. J. Hutchings,et al. Opportunities for therapeutic antibodies directed at G-protein-coupled receptors , 2017, Nature Reviews Drug Discovery.
[113] Kirstie A. Cummings,et al. The BigLEN-GPR171 Peptide Receptor System Within the Basolateral Amygdala Regulates Anxiety-Like Behavior and Contextual Fear Conditioning , 2017, Neuropsychopharmacology.
[114] A. Stamford,et al. Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist. , 2000, Biochemical pharmacology.
[115] Paul A. Insel,et al. G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs? , 2018, Molecular Pharmacology.
[116] T. Schöneberg,et al. Identification of the tethered peptide agonist of the adhesion G protein-coupled receptor GPR64/ADGRG2. , 2015, Biochemical and biophysical research communications.
[117] T. Schöneberg,et al. Progress in demystification of adhesion G protein-coupled receptors , 2013, Biological chemistry.
[118] M. Trincavelli,et al. The Recently Identified P2Y-Like Receptor GPR17 Is a Sensor of Brain Damage and a New Target for Brain Repair , 2008, PloS one.
[119] R. Abagyan,et al. RETRACTED ARTICLE: Orphan receptor ligand discovery by pickpocketing pharmacological neighbors , 2016, Nature Chemical Biology.
[120] R. Jockers,et al. Hunting for the function of orphan GPCRs – beyond the search for the endogenous ligand , 2015, British journal of pharmacology.
[121] R. Meyer,et al. GPR37 surface expression enhancement via N-terminal truncation or protein-protein interactions. , 2009, Biochemistry.
[122] Meryem Köse,et al. Development of [(3)H]2-Carboxy-4,6-dichloro-1H-indole-3-propionic Acid ([(3)H]PSB-12150): A Useful Tool for Studying GPR17. , 2014, ACS medicinal chemistry letters.
[123] K. Monk,et al. G Protein-Coupled Receptors in Myelinating Glia. , 2016, Trends in pharmacological sciences.
[124] A. Parrill,et al. GPRC6A Mediates the Non-genomic Effects of Steroids* , 2010, The Journal of Biological Chemistry.
[125] Veena P Menon,et al. Discovery and SAR of a Series of Agonists at Orphan G Protein-Coupled Receptor 139. , 2011, ACS medicinal chemistry letters.
[126] F. Chiodi,et al. Toll-Like Receptor 3 Signalling UpRegulates Expression of the HIV Co-Receptor G-Protein Coupled Receptor 15 on Human CD 4 ( + ) T Cells , 2014 .
[127] Lakshmi A. Devi,et al. Advancements in therapeutically targeting orphan GPCRs , 2015, Front. Pharmacol..
[128] G. Milligan,et al. Agonist activation of the G protein‐coupled receptor GPR35 involves transmembrane domain III and is transduced via Gα13 and β‐arrestin‐2 , 2011, British journal of pharmacology.
[129] D. Hay,et al. Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25 , 2018, British journal of pharmacology.
[130] M. Hollenberg,et al. International Union of Pharmacology. XXVIII. Proteinase-Activated Receptors , 2002, Pharmacological Reviews.
[131] Daniel Schulz,et al. Decoding Signaling and Function of the Orphan G Protein–Coupled Receptor GPR17 with a Small-Molecule Agonist , 2013, Science Signaling.
[132] Michihiro Mieda. The roles of orexins in sleep/wake regulation , 2017, Neuroscience Research.
[133] Charles N. Serhan,et al. Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.
[134] Jilly F. Evans,et al. Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7 , 2014, British journal of pharmacology.
[135] Gunnar Kleinau,et al. Identification of GPR83 as the receptor for the neuroendocrine peptide PEN , 2016, Science Signaling.
[136] D. Donnelly,et al. The GIP Receptor Displays Higher Basal Activity than the GLP-1 Receptor but Does Not Recruit GRK2 or Arrestin3 Effectively , 2014, PloS one.
[137] T. Horvath,et al. FoxO1 Target Gpr17 Activates AgRP Neurons to Regulate Food Intake , 2012, Cell.
[138] T. Südhof,et al. A novel evolutionarily conserved domain of cell-adhesion GPCRs mediates autoproteolysis , 2012, The EMBO journal.
[139] Ryan T. Strachan,et al. GPCR-G Protein-β-Arrestin Super-Complex Mediates Sustained G Protein Signaling , 2016, Cell.
[140] M. Rudd,et al. Structural Basis for Selectivity and Diversity in Angiotensin II Receptors , 2017, Nature.
[141] D. Littman,et al. Expression cloning of new receptors used by simian and human immunodeficiency viruses , 1997, Nature.
[142] Maria F. Sassano,et al. PRESTO-TANGO: an open-source resource for interrogation of the druggable human GPCR-ome , 2015, Nature Structural &Molecular Biology.
[143] Samantha L. Hoopes,et al. Vascular actions of 20-HETE. , 2015, Prostaglandins & other lipid mediators.
[144] M. Hentzer,et al. Protection of Primary Dopaminergic Midbrain Neurons by GPR139 Agonists Supports Different Mechanisms of MPP+ and Rotenone Toxicity , 2016, Front. Cell. Neurosci..
[145] G. Ferry,et al. A Generic Approach for the Purification of Signaling Complexes That Specifically Interact with the Carboxyl-terminal Domain of G Protein-coupled Receptors*S , 2008, Molecular & Cellular Proteomics.
[146] J. Kwak,et al. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils. , 2003, Molecular pharmacology.
[147] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[148] John P. Overington,et al. How many drug targets are there? , 2006, Nature Reviews Drug Discovery.
[149] Kazuhiko Inoue,et al. N-arachidonoyl glycine induces macrophage apoptosis via GPR18. , 2012, Biochemical and biophysical research communications.
[150] T. K. Harden,et al. Is GPR17 a P2Y/Leukotriene Receptor? Examination of Uracil Nucleotides, Nucleotide Sugars, and Cysteinyl Leukotrienes as Agonists of GPR17 , 2013, The Journal of Pharmacology and Experimental Therapeutics.
[151] Adam J Pawson,et al. Gonadotropin-releasing hormone receptors. , 2004, Endocrine reviews.
[152] C. J. Hutchings,et al. Monoclonal anti-β1-adrenergic receptor antibodies activate G protein signaling in the absence of β-arrestin recruitment , 2014, mAbs.
[153] GPR139, an Orphan Receptor Highly Enriched in the Habenula and Septum, Is Activated by the Essential Amino Acids l-Tryptophan and l-Phenylalanine , 2015, Molecular Pharmacology.
[154] C. Serhan,et al. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. , 2004, Prostaglandins & other lipid mediators.
[155] A. Davenport,et al. Evolving pharmacology of orphan GPCRs: IUPHAR Commentary , 2013, British journal of pharmacology.
[156] T. Kenakin. Cellular assays as portals to seven-transmembrane receptor-based drug discovery , 2009, Nature Reviews Drug Discovery.
[157] A. Ardati,et al. A new family of orphan G protein‐coupled receptors predominantly expressed in the brain 1 , 1998, FEBS letters.
[158] C. Serhan,et al. Resolvins , 2002, The Journal of Experimental Medicine.
[159] W. Samson,et al. Evidence for an interaction between proinsulin C-peptide and GPR146. , 2013, The Journal of endocrinology.
[160] Arthur Christopoulos,et al. A simple method for quantifying functional selectivity and agonist bias. , 2012, ACS chemical neuroscience.
[161] R. Adan,et al. AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. , 2001, Molecular endocrinology.
[162] Thomas de Quincey. [C] , 2000, The Works of Thomas De Quincey, Vol. 1: Writings, 1799–1820.
[163] E. Butcher,et al. A Mucosal and Cutaneous Chemokine Ligand for the Lymphocyte Chemoattractant Receptor GPR15 , 2017, Front. Immunol..
[164] M. Glass,et al. GPR18 undergoes a high degree of constitutive trafficking but is unresponsive to N-Arachidonoyl Glycine , 2016, PeerJ.
[165] R. Takahashi,et al. Pael‐R is accumulated in Lewy bodies of Parkinson's disease , 2004, Annals of neurology.
[166] Bryan L Roth,et al. Integrated Approaches for Genome-wide Interrogation of the Druggable Non-olfactory G Protein-coupled Receptor Superfamily* , 2015, The Journal of Biological Chemistry.
[167] Albert C. Pan,et al. The Dynamic Process of β2-Adrenergic Receptor Activation , 2013, Cell.
[168] G. Milligan. Orthologue selectivity and ligand bias: translating the pharmacology of GPR35. , 2011, Trends in pharmacological sciences.
[169] S. Tenzer,et al. Cell Type-Specific Tandem Affinity Purification of the Mouse Hippocampal CB1 Receptor-Associated Proteome. , 2016, Journal of proteome research.
[170] J. Lupski,et al. Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. , 2014, The New England journal of medicine.
[171] R. Jockers,et al. Do orphan G‐protein‐coupled receptors have ligand‐independent functions? , 2006, EMBO reports.
[172] T. Kenakin. Functional Selectivity and Biased Receptor Signaling , 2011, Journal of Pharmacology and Experimental Therapeutics.
[173] T. Schöneberg,et al. Activation of Adhesion G Protein-coupled Receptors , 2017, The Journal of Biological Chemistry.
[174] H. Schaller,et al. The neuropeptide head activator is a high-affinity ligand for the orphan G-protein-coupled receptor GPR37 , 2006, Journal of Cell Science.
[175] B. Monsarrat,et al. Purification and Identification of G Protein-coupled Receptor Protein Complexes under Native Conditions*S , 2007, Molecular & Cellular Proteomics.
[176] S. Ikeda,et al. Inhibition of N-Type Calcium Channels by Activation of GPR35, an Orphan Receptor, Heterologously Expressed in Rat Sympathetic Neurons , 2008, Journal of Pharmacology and Experimental Therapeutics.
[177] A. Ferguson,et al. Neuronostatin Encoded by the Somatostatin Gene Regulates Neuronal, Cardiovascular, and Metabolic Functions* , 2008, Journal of Biological Chemistry.
[178] Yunpeng Wu,et al. GPRC6A mediates responses to osteocalcin in β‐cells in vitro and pancreas in vivo , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[179] Kirsten B. Andersen,et al. The orphan G protein-coupled receptor GPR139 is activated by the peptides: Adrenocorticotropic hormone (ACTH), α-, and β-melanocyte stimulating hormone (α-MSH, and β-MSH), and the conserved core motif HFRW , 2017, Neurochemistry International.
[180] M. Mezei,et al. Identification of a small-molecule ligand that activates the neuropeptide receptor GPR171 and increases food intake , 2016, Science Signaling.
[181] Hans Clevers,et al. Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling , 2011, Nature.
[182] Christopher Southan,et al. The Concise Guide to PHARMACOLOGY 2015/16: G protein‐coupled receptors , 2015, British journal of pharmacology.
[183] G. Fitzgerald,et al. 'I. , 2019, Australian journal of primary health.
[184] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[185] F. Chiodi,et al. Toll-Like Receptor 3 Signalling Up-Regulates Expression of the HIV Co-Receptor G-Protein Coupled Receptor 15 on Human CD4+ T Cells , 2014, PloS one.
[186] J. Wess,et al. Lack of beta-arrestin signaling in the absence of active G proteins , 2018, Nature Communications.
[187] J. Wahren,et al. C‐peptide and long‐term complications of diabetes , 2011, Pediatric diabetes.
[188] J. Violin,et al. Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection. , 2007, The Journal of clinical investigation.
[189] H. Rang. The receptor concept: pharmacology's big idea , 2006, British journal of pharmacology.
[190] R. Lefkowitz,et al. β-Arrestins and Cell Signaling , 2007 .
[191] Liaoyuan A. Hu,et al. Identification of Surrogate Agonists and Antagonists for Orphan G-Protein-Coupled Receptor GPR139 , 2009, Journal of biomolecular screening.
[192] J. Konkel,et al. Transforming Growth Factor‐&bgr; Signaling in Regulatory T Cells Controls T Helper‐17 Cells and Tissue‐Specific Immune Responses , 2017, Immunity.
[193] Ryan T. Strachan,et al. Regulation of Beta-2-Adrenergic Receptor Function by Conformationally Selective Single-domain Intrabodies , 2013 .
[194] J. Falck,et al. 20-HETE Signals Through G-Protein–Coupled Receptor GPR75 (Gq) to Affect Vascular Function and Trigger Hypertension , 2017, Circulation research.
[195] G. Sumara,et al. Endocrine Regulation of Male Fertility by the Skeleton , 2011, Cell.
[196] N. Hattori,et al. An Unfolded Putative Transmembrane Polypeptide, which Can Lead to Endoplasmic Reticulum Stress, Is a Substrate of Parkin , 2001, Cell.
[197] M. Neurath,et al. Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo , 2015, Gut.
[198] David E. Gloriam,et al. Trends in GPCR drug discovery: new agents, targets and indications , 2017, Nature Reviews Drug Discovery.
[199] R. Lefkowitz,et al. Direct Binding of Activated c-Src to the β3-Adrenergic Receptor Is Required for MAP Kinase Activation* , 2000, The Journal of Biological Chemistry.
[200] R. Lefkowitz,et al. β-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7 , 2009, Proceedings of the National Academy of Sciences.
[201] Aaron Naatz,et al. Neuronostatin acts via GPR107 to increase cAMP-independent PKA phosphorylation and proglucagon mRNA accumulation in pancreatic α-cells. , 2016, American journal of physiology. Regulatory, integrative and comparative physiology.